Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide
โ Scribed by Fa-Chyi Lee; Shakil H. Merchant
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 209 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We describe a 74-year-old patient with multicentric Castleman's disease (MCD) whose serum macrophage colony-stimulating factor level was elevated. Serum levels of tumor necrosis factor-โฃ and interleukin 6 were also elevated at presentation, and they returned to normal levels after chemotherapy. Alth
## Background: Castleman's disease (cd), or angiofollicular lymph node hyperplasia, creates both diagnostic and therapeutic dilemmas for most physicians. for patients with this rare and poorly understood disease, the optimal therapy is unknown. the authors report their experience during the years 1